logo
Share SHARE
FONT-SIZE Plus   Neg

Bristol-Myers Squibb, Gladstone Institutes Enter 3-yr Discovery Partnership

Bristol-Myers Squibb Co. (BMY) and the Gladstone Institutes announced the formation of a discovery-based research collaboration to identify and validate novel targets in Alzheimer's disease.

As per the agreement, Bristol-Myers Squibb will fund Gladstone's research efforts to identify targets that affect Tau dysfunction. Tau is a protein that binds the cell's internal skeleton and may help regulate the activity of brain cells.

In Alzheimer's disease, Tau forms abnormal deposits called neurofibrillary tangles, a hallmark pathology of the disease. By identifying targets that prevent or reverse Tau dysfunction, Bristol-Myers Squibb and Gladstone hope to identify novel therapeutic strategies to modify the course of the disease.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
GameStop reported an increase in second-quarter profit, driven by strong same-store sales growth and improved margins, partly offset by a stronger dollar and one-time charges. Both earnings and sales surpassed Wall Street estimates. The video-game retailer lifted its guidance for 2015. GameStop shares gained about 2 percent in after-hours trade. French conglomerate Bouygues SA reported Thursday a net loss for the first half compared to a profit last year, which was boosted by a gain on Cofiroute unit stake sale. However, sales edged up 1 percent from last year. The company raised its 2015 outlook for Bouygues Telecom and confirmed its forecast for the construction businesses and TF1 television business. Kraft Heinz is recalling more than two million pounds of Oscar Mayer turkey bacon as it may prematurely spoil and on reports of people becoming unwell after eating certain items.
comments powered by Disqus
Follow RTT